Alexander J. Chase
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Alexander J. Chase has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ayush Khurana
Morriston Hosp, Morriston Reg Cardiac Ctr, Dept Cardiol, Heol Maes Eglwys, Swansea SA6 6NL, Wales
2 shared publications - David Smith
Morriston Hosp, Morriston Reg Cardiac Ctr, Dept Cardiol, Heol Maes Eglwys, Swansea SA6 6NL, Wales
2 shared publications - Omar Aldalati
Univ Hosp Wales, Dept Cardiol, Heath Pk, Cardiff CF14 4XW, Wales
2 shared publications - Ahmed Hailan
Morriston Cardiac Centre, Swansea, UK
1 shared publication - Andrei D. Margulescu
Department of Cardiology, Morriston Regional Cardiac Centre, Morriston Hospital, Swansea SA6 6NL, UK
1 shared publication - Baskar Sekar
Department of Cardiology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, United Kingdom
1 shared publication
Latest Publications
- 5 April 2024
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 68, 23-29
Prevalence and progression of LV dysfunction and dyssynchrony in patients with new-onset LBBB post TAVR
- 5 April 2024
- Published by Elsevier in Cardiovascular Revascularization Medicine
- Vol. 68, 23-29
Prevalence and progression of LV dysfunction and dyssynchrony in patients with new-onset LBBB post TAVR
- Open Access
- 24 October 2023
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 96 (1152) , 20230296
Computed tomography defined femoral artery plaque composition predicts vascular complications during transcatheter aortic valve implantation
Objective: Vascular and bleeding complications after transcatheter aortic valve implantation (TAVI) are common and lead to increased morbidity and mortality. Analysis of plaque at the arterial access site may improve prediction of complications. Methods: We investigated the association between demographic and procedural risk factors for Valve Academic Research Consortium (VARC-3) vascular complications in patients undergoing transfemoral TAVI with use of a vascular closure device (ProGlide® or MANTA®) in this retrospective cohort study. The ability of pre-procedure femoral CT angiography to predict complications was investigated including a novel method of quantifying plaque composition of the common femoral artery using plaque maps created with patient specific X-ray attenuation cut-offs. Results: 23 vascular complications occurred in the 299 patients in the study group (7.7%). There were no demographic risk factors associated with vascular complications and no statistical difference between use of closure device (ProGlide®vs MANTA®) and vascular complications. Vascular complications after TAVI were associated with sheath size (OR 1.36, 95% CI 1.08–1.76, P 0.01) and strongly associated with CT-derived necrotic core volume in the common femoral artery of the procedural side (OR 17.49, 95% CI 1.21–226.60, P 0.03). Conclusion: Plaque map analysis of the common femoral artery by CT angiography reveals patients with greater necrotic core are at increased risk of VARC-3 vascular complications. Advances in knowledge: The novel measurement of necrotic core volume in the common femoral artery on the procedural side by CT analysis was associated with post-TAVI vascular complications, which can be used to highlight increased risk.
- 24 October 2023
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 96 (1152) , 20230296
Open AccessComputed tomography defined femoral artery plaque composition predicts vascular complications during transcatheter aortic valve implantation
Objective: Vascular and bleeding complications after transcatheter aortic valve implantation (TAVI) are common and lead to increased morbidity and mortality. Analysis of plaque at the arterial access site may improve prediction of complications. Methods: We investigated the association between demographic and procedural risk factors for Valve Academic Research Consortium (VARC-3) vascular complications in patients undergoing transfemoral TAVI with use of a vascular closure device (ProGlide® or MANTA®) in this retrospective cohort study. The ability of pre-procedure femoral CT angiography to predict complications was investigated including a novel method of quantifying plaque composition of the common femoral artery using plaque maps created with patient specific X-ray attenuation cut-offs. Results: 23 vascular complications occurred in the 299 patients in the study group (7.7%). There were no demographic risk factors associated with vascular complications and no statistical difference between use of closure device (ProGlide®vs MANTA®) and vascular complications. Vascular complications after TAVI were associated with sheath size (OR 1.36, 95% CI 1.08–1.76, P 0.01) and strongly associated with CT-derived necrotic core volume in the common femoral artery of the procedural side (OR 17.49, 95% CI 1.21–226.60, P 0.03). Conclusion: Plaque map analysis of the common femoral artery by CT angiography reveals patients with greater necrotic core are at increased risk of VARC-3 vascular complications. Advances in knowledge: The novel measurement of necrotic core volume in the common femoral artery on the procedural side by CT analysis was associated with post-TAVI vascular complications, which can be used to highlight increased risk.